RecruitingNot ApplicableNCT04725656

Concentration Impact Nicotine Salt

Impact of the Nicotine Concentration on the Efficacy of a Nicotine Salt Vape Pod System as Smoking Cessation Tool

Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

312 participants

Start Date

Jan 30, 2024

Study Type

INTERVENTIONAL

Conditions

Vaping Smoking Cessation

Summary

Double-blind (for the two active arms), randomized, three-arm (two active and one control) clinical trial investigating factors (e.g. nicotine concentration) influencing the success of smoking cessation strategies and possible health risks related to nicotine salt vaping.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Open system vape device and nicotine salt e-liquids and a procedure called Smoking cessation counseling for people with smoking cessation and vaping. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.